INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $24,000 | +100.0% | 20,500 | +5.1% | 0.00% | – |
| Q2 2022 | $12,000 | -45.5% | 19,500 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | -50.0% | 19,500 | 0.0% | 0.00% | – |
| Q4 2021 | $44,000 | -34.3% | 19,500 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $67,000 | +15.5% | 19,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $58,000 | -7.9% | 19,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $63,000 | – | 19,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |